Home Page | XELJANZ® (tofacitinib) | Safety Info

The safety information below applies to all marketed formulations of XELJANZ. Specific risks associated with certain dosing is noted. Serious Infections. XELJANZ can lower the ability of your immune system to fight infections. Do not start taking XELJANZ if you have any kind of infection unless your healthcare provider tells you it is okay. Serious Infections have happened in people taking X...

unsafe advertisement

2.48 Rating by Usitestat

xeljanz.com was registered 1 decade 5 years ago. It has a alexa rank of #555,405 in the world. It is a domain having .com extension. It is estimated worth of $ 2,400.00 and have a daily income of around $ 10.00. As no active threats were reported recently, xeljanz.com is SAFE to browse.

Updated 3 years 4 months ago

Traffic Report

Daily Unique Visitors:	1,579
Daily Pageviews:	3,158

Estimated Valuation

Income Per Day:	$ 10.00
Estimated Worth:	$ 2,400.00

Search Engine Indexes

Google Indexed Pages:	Not Applicable
Yahoo Indexed Pages:	Not Applicable
Bing Indexed Pages:	Not Applicable

Search Engine Backlinks

Google Backlinks:	Not Applicable
Bing Backlinks:	Not Applicable
Alexa BackLinks:	Not Applicable

Safety Information

Google Safe Browsing:	No Risk Issues
Siteadvisor Rating:	Not Applicable
WOT Trustworthiness:	Very Poor
WOT Privacy:	Very Poor
WOT Child Safety:	Very Poor

Website Ranks & Scores

Alexa Rank:	555,405
PageSpeed Score:	89 ON 100
Domain Authority:	49 ON 100
Bounce Rate:	Not Applicable
Time On Site:	Not Applicable

Web Server Information

Hosted IP Address:

143.204.98.43

Hosted Country:

Location Latitude:

50.1155

Location Longitude:

8.68417

unsafe advertisement

Traffic Classification

Total Traffic:	680.09K
Direct Traffic:	14.11%
Referral Traffic:	7.28%
Search Traffic:	36.47%
Social Traffic:	0%
Mail Traffic:	0.66%
Display Traffic:	41.49%

Search Engine Results For xeljanz.com

Enbrel vs. Xeljanz Prescription Treatment for Rheumatoid Arthritis ...

- https://www.rxlist.com/enbrel_vs_xeljanz/drugs-condition.htm

Enbrel (etanercept) and Xeljanz (tofacitinib citrate) are used to treat rheumatoid arthritis. Enbrel is also used to treat juvenile idiopathic arthritis, ankylosing ...

Xeljanz XR Prices, Coupons & Savings Tips - GoodRx

- https://www.goodrx.com/xeljanz-xr

Compare prices, print coupons and get savings tips for Xeljanz XR and other Rheumatoid Arthritis drugs at CVS, Walgreens, and other pharmacies. Prices start ...

Tofacitinib - Wikipedia

- https://en.wikipedia.org/wiki/Tofacitinib

Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Common side ...

Xeljanz

- https://xeljanz.com.au/

Please find tailored information and support for healthcare professionals and patients prescribed XELJANZ below. BEFORE PRESCRIBING, PLEASE REVIEW ...

Xeljanz oral: Uses, Side Effects, Interactions, Pictures, Warnings ...

- https://www.webmd.com/drugs/2/drug-162865/xeljanz-oral/details

Generic Name: tofacitinib ... Tofacitinib is used to treat certain types of arthritis ( such as psoriatic arthritis, rheumatoid arthritis, polyarticular course juvenile...

Xeljanz | European Medicines Agency

- https://www.ema.europa.eu/en/medicines/human/EPAR/xeljanz

Xeljanz is a medicine for treating adults with moderate to severe rheumatoid arthritis, a disease that causes inflammation of the joints, and psoriatic arthritis ( red, ...

Initial safety trial results find increased risk of serious...

- https://www.fda.gov/drugs/drug-safety-and-availability/initial-safety-trial-results-find-increased-risk-serious-heart-related-problems-and-cancer-arthritis

Feb 4, 2021 ... Preliminary safety trial results show an increased risk of serious heart-related problems and cancer with Xeljanz, Xeljanz XR (tofacitinib).

XELSOURCE Patient Assistance Program Application

- https://www.pfizerpro.com/sites/default/files/xelsource-patient-assistance-program-application.pdf

XELJANZ/XELJANZ XR is used to treat adults with active psoriatic arthritis in which methotrexate or other similar medicines called nonbiologic disease- modifying.

Tofacitinib Citrate (Xeljanz) - American College of Rheumatology

- https://www.rheumatology.org/I-Am-A/Patient-Caregiver/Treatments/Tofacitinib-Citrate-Xeljanz

Tofacitinib Citrate (Xeljanz) is an oral, small molecule drug used to treat adults with moderate to severe active rheumatoid arthritis (RA), active psoriatic arthritis, ...

Medications (Text-Based Page) - Infusion Solutions of Delaware

- http://infusede.com/treatments/medications-text-based-page/

Actemra; Benlysta; Boniva; Cimzia; Orencia; Prolia; Reclast; Remicade; Rituxan; Xeljanz; Kevzara; Olumiant; Rinvoq; Siliq; Skyrizi; Taltz; Tremfya; Tymlos ...

Home Page | XELJANZ® (tofacitinib) | Safety Info

- https://www.xeljanz.com/

XELJANZ is a registered trademark of Pfizer Inc. The brand names included throughout are the properties of their respective owners. XELJANZ (tofacitinib) is ...

Tips that may help manage life with a chronic illness - AP News

- https://apnews.com/article/539cf633833c45499230dbe9b481b3a6

Mar 25, 2019 ... XELJANZ/XELJANZ XR can lower the ability of your immune system to fight infections. Some people can have serious infections while taking ...

Put Your Health First: Learning What Works for Your Chronic ...

- https://www.statesman.com/ZZ/sponsored/20190430/put-your-health-first-learning-what-works-for-your-chronic-inflammatory-illness

Apr 30, 2019 ... With XELJANZ and his RA treatment plan, he was able to manage his symptoms. Common side effects of XELJANZ/XELJANZ XR in rheumatoid ...

Meet Stephanie: Xeljanz UC patient - Bean LabsBean Labs

- https://beanlabs.com/project/meet-stephanie-xeljanz-uc-patient/

XELJANZ/XELJANZ XR may cause serious side effects. Learn more about the Most Important Risk Information you should know about XELJANZ/XELJANZ XR.

Xeljanz/Xeljanz XR | Advertising Profile | See Their Ad Spend ...

- https://advertisers.mediaradar.com/xeljanzxeljanz-xr-advertising-profile

Xeljanz/Xeljanz XR's advertising profile, including ad spend, recent creative, company contacts, & the analysis you need to reach key decision makers and ...

Tofacitinib: Drug information - UpToDate

- https://www.uptodate.com/contents/tofacitinib-drug-information/print

Health Canada has reviewed the risk of venous thromboembolic events (VTE) and pulmonary embolism with Xeljanz and Xeljanz XR (tofacitinib) after early results ...

Learn About Xeljanz That: An RX Medicine For Adults with moderate ...

- https://www.arthritis.org/partnership/ease-of-use-products/xeljanz

Xeljanz is a prescription used to treat rheumatoid arthritis without methotrexate, which comes in an easy-to-open bottle.

XELJANZ® (tofacitinib citrate) Receives Marketing Authorization in ...

- https://www.businesswire.com/news/home/20180731006055/en/XELJANZ®-tofacitinib-citrate-Receives-Marketing-Authorization-in-the-European-Union-for-Moderately-to-Severely-Active-Ulcerative-Colitis

Aug 1, 2018 ... XELJANZ is the first and only oral therapy and Janus kinase (JAK) inhibitor to be approved for this patient population. “Forward-Looking ...

Xeljanz Treats Rheumatoid Arthritis - Overview - YouTube

- https://www.youtube.com/watch?v=3EXw2Efja2w

May 21, 2015 ... Xeljanz belongs to a group of drugs called JAK inhibitors which work by suppressing the immune system against the damaging inflammation of ...

TOFACITINIB What is Tofacitinib? Tofacitinib (Xeljanz®) is an ...

- https://www.massgeneral.org/assets/MGH/pdf/digestive/crohns-colitis/drug_information_handout_tofacitinib.pdf

Tofacitinib (Xeljanz®) is an antibody against a group of enzymes (Janus kinases, JAK) that trigger inflammation. It is approved for the treatment of ulcerative ...

SPECIALTY QUANTITY LIMIT PROGRAM

- https://www.shpnc.org/documents/files/specialty-quantity-limit-xeljanz-xeljanz-xr-2091-h-p2019a/open

Page Resources Breakdown

Homepage Links Analysis

Page Title of xeljanz.com

Home Page | XELJANZ® (tofacitinib) | Safety Info

Meta Description of xeljanz.com

See risks and benefits of XELJANZ®/XELJANZ® XR (tofacitinib) Rx med for adults with moderate/severe RA, active PsA & moderate/severe UC after certain medicines.

Website Inpage Analysis

H1 Headings:	10	H2 Headings:	2
H3 Headings:	Not Applicable	H4 Headings:	Not Applicable
H5 Headings:	Not Applicable	H6 Headings:	Not Applicable
Total IFRAMEs:	Not Applicable	Total Images:	28
Google Adsense:	Not Applicable	Google Analytics:	Not Applicable

Two Phrase Analysis

Words	Occurrences	Density	Possible Spam
healthcare provider	51	0.711 %	No
your healthcare	42	0.586 %	No
if you	41	0.572 %	No
is not	30	0.418 %	No
you have	29	0.404 %	No
of the	26	0.363 %	No
taking XELJANZ	24	0.335 %	No
in the	24	0.335 %	No
provider if	21	0.293 %	No
you are	19	0.265 %	No
rheumatoid arthritis	19	0.265 %	No
adults with	17	0.237 %	No
It is	15	0.209 %	No
Tell your	15	0.209 %	No
not known	15	0.209 %	No
an infection	15	0.209 %	No
dose of	15	0.209 %	No
known if	15	0.209 %	No
XELJANZXELJANZ XR	15	0.209 %	No
Pfizer Inc	14	0.195 %	No

Four Phrase Analysis

Words	Occurrences	Density	Possible Spam
your healthcare provider if	21	0.293 %	No
healthcare provider if you	21	0.293 %	No
Tell your healthcare provider	15	0.209 %	No
is not known if	15	0.209 %	No
It is not known	15	0.209 %	No
not work well or	10	0.139 %	No
did not work well	10	0.139 %	No
or cannot be tolerated	10	0.139 %	No
well or cannot be	10	0.139 %	No
work well or cannot	10	0.139 %	No
right away if you	9	0.126 %	No
provider right away if	9	0.126 %	No
away if you have	9	0.126 %	No
provider if you have	9	0.126 %	No
Hepatitis B or C	9	0.126 %	No
if you have any	9	0.126 %	No
safe and effective in	9	0.126 %	No
is safe and effective	9	0.126 %	No
tell your healthcare provider	9	0.126 %	No
of age and older	9	0.126 %	No

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Content-Type: text/html
Transfer-Encoding: chunked
Connection: keep-alive
x-amz-id-2: cbGWsEDGYEE1eKvy03L6TbRbpcCZ4/Vwx5ADfJgDwie82knJX2T1NevRIW5GIs8Ia8DtkVzmrOs=
x-amz-request-id: 356CKTJDVA114R4C
Last-Modified: Wed, 16 Jun 2021 07:20:12 GMT
x-amz-server-side-encryption: AES256
Server: AmazonS3
Strict-Transport-Security: max-age=31536000; includeSubdomains; preload
Content-Security-Policy: default-src 'none'; report-uri https://pfeprod.report-uri.com/r/t/csp/enforce; child-src 'self' blob:; connect-src 'self' https://*.akafms.net/ https://*.akamaihd.net/ https://*.brightcove.com/ https://*.brightcovecdn.com/ https://*.brightcove.net/ https://*.digitalpfizer.com/ https://*.evidon.com/ https://*.hotjar.com/ https://*.llnw.net/ https://*.llnwd.net/ https://1vrf04rusa.execute-api.eu-west-1.amazonaws.com/ https://223i44638a.execute-api.eu-west-1.amazonaws.com/ https://6q7zxrfi35.execute-api.eu-west-1.amazonaws.com/ https://amer-identity.pfizer.com/ https://appsapi.veinteractive.com/api/ https://brightcove.hs.llnwd.net/ https://cdn.pfizer.com/ https://cdn-dev.pfizer.com/ https://code.jquery.com/ https://cookiee1.veinteractive.com/api/ https://drs2.veinteractive.com/ https://dpm.demdex.net/ https://edge.api.brightcove.com/ https://emea-identity.pfizer.com/ https://f1.media.brightcove.com/ https://geoip-js.maxmind.com/geoip/v2.1/country/ https://house-cloudfront.ap-northeast-1.prod.boltdns.net/ https://house-cloudfront.ap-southeast-1.prod.boltdns.net/ https://house-cloudfront.ap-southeast-2.prod.boltdns.net/ https://house-cloudfront.eu-west-1.prod.boltdns.net/ https://house-cloudfront.us-east-1.prod.boltdns.net/ https://manifest.prod.boltdns.net/ https://in.hotjar.com/api/v2/client/sites/ https://l.betrad.com/ https://loremflickr.com/ https://metrics.articulate.com/ https://newton-api.eu.cloudhub.io https://pfe-dse-dar-poc.auth.us-east-1.amazoncognito.com/ https://pfizer.sc.omtrdc.net/ https://players.brightcove.net/ https://secure.brightcove.com/services/mobile/streaming/ https://sessionapi.veinteractive.com/ https://sitecatalyst.omniture.com/sc15/activitymap/ https://storybook.js.org/ https://tagmanager.google.com/ https://vlswbkfag3.execute-api.eu-west-1.amazonaws.com/ https://vc.hotjar.io/ https://vc.hotjar.io/views/ https://www.google-analytics.com/ https://www.facebook.com/ wss://*.hotjar.com/ wss://*.pfizer.com/ https://manifest.prod.boltdns.net/ https://house-fastly-signed-eu-west-1-prod.brightcovecdn.com/ https://pfraxeljanzcom-dev.pfizersite.io/js-api/submission https://pfraxeljanzcom-dev.pfizersite.io/js-api/ddg https://pfraxeljanzcom-dev.pfizersite.io/js-api/question https://pfraxeljanzcom-dev.pfizersite.io/js-api/glossary https://pfraxeljanzcom-dev.pfizersite.io/quickauth/getoken https://pfraxeljanzcom-stage.pfizersite.io/js-api/glossary https://pfraxeljanzcom-stage.pfizersite.io/js-api/submission https://pfraxeljanzcom-stage.pfizersite.io/js-api/ddg https://pfraxeljanzcom-stage.pfizersite.io/js-api/question https://pfraxeljanzcom-stage.pfizersite.io/quickauth/getoken https://api.xeljanz.com/js-api/submission https://api.xeljanz.com/js-api/ddg https://api.xeljanz.com/js-api/question https://api.xeljanz.com/js-api/glossary https://api.xeljanz.com/quickauth/getoken https://*.hotjar.com/; font-src 'self' data: https://*.digitalpfizer.com/ https://canvas.pfizer.com/ https://cdnjs.cloudflare.com/ https://docs.gcs.digitalpfizer.com/fonts/ https://fast.fonts.net/ https://fast.fonts.net/dv2/1 https://fonts.googleapis.com/ https://fonts.gstatic.com/ https://pfcopayoffers-stage.pfizersite.io/ https://pkg-cdn.digitalpfizer.com/ https://quilt-cdn.janrain.com/HEAD/JanrainIcons.eot https://quilt-cdn.janrain.com/HEAD/JanrainIcons.svg https://maxcdn.bootstrapcdn.com/font-awesome/ https://script.hotjar.com https://use.fontawesome.com/releases/ https://vjs.zencdn.net/ https://use.typekit.net/; frame-ancestors 'self'; frame-src 'self' https://*.fls.doubleclick.net/ https://activitymap.adobe.com/sc15/activitymap/ https://bid.g.doubleclick.net/ https://config1.veinteractive.com/ https://l3.evidon.com/ https://platform.twitter.com/ https://players.brightcove.net/ https://player.vimeo.com/ https://player.vimeo.com/video https://staticxx.facebook.com/ https://syndication.twitter.com/ https://vars.hotjar.com/ https://v5.organimi.com/ https://where-to-buy.co/ https://www.facebook.com/ https://www.google.com/maps/ https://www.youtube.com/ https://www.google.com/; img-src 'self' blob: data: https://* https://cf-images.eu-west-1.prod.boltdns.net/ https://maps.gstatic.com/ https://segment.a3cloud.net/ https://segment.a3cloud.net/px.png/; manifest-src 'self'; media-src 'self' blob: data: https://*.akafms.net/ https://*.akamaihd.net/ https://*.boltdns.net/ https://*.brightcovecdn.com/ https://*.llnw.net/ https://*.llnwd.net/ https://*.media.brightcove.com/ https://manifest.prod.boltdns.net/ https://secure.brightcove.com/services/mobile/streaming/ https://manifest.prod.boltdns.net https://manifest.prod.boltdns.net/manifest/v1/hls/v4 https://manifest.prod.boltdns.net/manifest/v1/hls/v4/clear/1852113022001 https://manifest.prod.boltdns.net/manifest/v1/hls/v4/clear/1852113022001/4b04046b-5473-4ab7-8feb-374c4bc35537/10s https://manifest.prod.boltdns.net/manifest/v1/hls/v4/clear/1852113022001/4b04046b-5473-4ab7-8feb-374c4bc35537/10s/master.m3u8 https://manifest.prod.boltdns.net/manifest/v1/hls/v4/clear/1852113022001/4b04046b-5473-4ab7-8feb-374c4bc35537/10s/master.m3u8/ https://house-fastly-signed-eu-west-1-prod.brightcovecdn.com/media/v1/hls/v4/clear/; object-src 'self' https://players.brightcove.net/; prefetch-src 'self' https://*.boltdns.net/; script-src 'self' 'unsafe-eval' 'unsafe-inline' blob: https://*.digitalpfizer.com https://a.volvelle.tech/ https://*.janrain.com https://*.janraincapture.com https://*.janrainsso.com https://ajax.googleapis.com/ajax/ https://analytics.digitalpfizer.com/js/prod/pcc/ https://analytics.twitter.com/ https://assets.adobedtm.com/ https://assets.edison.sh/ https://canvas.pfizer.com/ https://cdnjs.cloudflare.com/ https://c.betrad.com/ https://c.evidon.com/ https://cdn.pfizer.com/ https://cdn-dev.pfizer.com/ https://l.evidon.com/ https://code.jquery.com/ https://connect.facebook.net/ https://cookies.pfizer.com/ https://config1.veinteractive.com/ https://fast.fonts.net/jsapi/ https://googleads.g.doubleclick.net/ https://js.maxmind.com/js/apis/geoip2/v2.1/ https://maps.googleapis.com/maps/api/ https://maps.googleapis.com/maps-api-v3/api/js/ https://maxcdn.bootstrapcdn.com/ https://pfcopayoffers-stage.pfizersite.io/ https://pkg-cdn.digitalpfizer.com/ https://platform.twitter.com/ https://players.brightcove.net/ https://player.vimeo.com/ https://player.vimeo.com/api/ https://px.veinteractive.com/ https://s3.amazonaws.com/docs.gcs.digitalpfizer.com/ https://s3.amazonaws.com/pfe_im/ https://s.ytimg.com/yts/jsbin/ https://sadmin.brightcove.com/js/ https://script.hotjar.com/ https://ssl.google-analytics.com/ https://static.ads-twitter.com/ https://static.hotjar.com/c/ https://tagmanager.google.com/ https://tpc.googlesyndication.com/sodar/ https://vjs.zencdn.net/ https://www.geoplugin.net/ https://www.googleadservices.com/pagead/ https://www.googletagmanager.com/ https://www.google-analytics.com/ https://www.gstatic.com/charts/ https://www.youtube.com/player_api https://ajax.aspnetcdn.com/ https://www.google.com/recaptcha/api.js https://www.gstatic.com/recaptcha/releases/ https://docs.gcs.digitalpfizer.com/fonts/fs_albert_pro_web/font_FSAlbert.js https://t.a3cloud.net/ https://t.a3cloud.net/AM-141133/tag.js/; style-src 'self' 'unsafe-inline' https://*.digitalpfizer.com/ https://*.janrain.com https://assets.edison.sh/ https://cdn.pfizer.com/ https://cdn-dev.pfizer.com/ https://cdnjs.cloudflare.com/ https://cloud.typography.com/ https://cookies.pfizer.com/ https://fast.fonts.net/ https://fonts.googleapis.com/ https://maxcdn.bootstrapcdn.com/ https://p.typekit.net/ https://pfcopayoffers-stage.pfizersite.io/ https://pfredirect.pfizersite.io/files/fonts/ https://pkg-cdn.digitalpfizer.com/ https://players.brightcove.net/ https://px.veinteractive.com/ https://quilt-cdn.janrain.com/HEAD/providers.css/ https://quilt-cdn.janrain.com/HEAD/widgets.css/ https://s3.amazonaws.com/docs.gcs.digitalpfizer.com/ https://stackpath.bootstrapcdn.com/ https://tagmanager.google.com/ https://use.typekit.net/ https://www.gstatic.com/charts/; worker-src 'self' blob:
X-Content-Type-Options: nosniff
X-XSS-Protection: 1; mode=block
X-Edison-Type: Lite
Referrer-Policy: same-origin
Report-To: {"group":"default","max_age":31536000,"endpoints":[{"url":"https://pfizer.report-uri.com/a/d/g"}],"include_subdomains":true}
Content-Encoding: gzip
Date: Tue, 22 Jun 2021 00:38:02 GMT
ETag: W/"1131091b510b9ba7d8bb778197866a33"
Vary: Accept-Encoding
X-Cache: Hit from cloudfront
Via: 1.1 a63182cf51dce7998774e112bf9ee7c6.cloudfront.net (CloudFront)
X-Amz-Cf-Pop: ZRH50-C1
X-Amz-Cf-Id: 1jJjGM28pGyTyZy8EfDHovfUQymH64vUwF25gLx65oVNLpczdV0ZGQ==
Age: 32461

Domain Information

Domain Registrar:	MarkMonitor Inc.
Registration Date:	2009-03-10 1 decade 5 years 8 months ago
Last Modified:	2021-02-06 3 years 9 months 2 weeks ago

Domain Nameserver Information

Host	IP Address	Country
ns1.p15.dynect.net	108.59.161.15	United States
ns2.p15.dynect.net	108.59.162.15	United States
ns3.p15.dynect.net	108.59.163.15	United States
ns4.p15.dynect.net	108.59.164.15	United States

DNS Record Analysis

Host	Type	TTL	Extra
xeljanz.com	A	298	IP: 143.204.98.43
xeljanz.com	A	298	IP: 143.204.98.59
xeljanz.com	A	298	IP: 143.204.98.120
xeljanz.com	A	298	IP: 143.204.98.104
xeljanz.com	NS	86400	Target: ns3.p15.dynect.net
xeljanz.com	NS	86400	Target: ns2.p15.dynect.net
xeljanz.com	NS	86400	Target: ns1.p15.dynect.net
xeljanz.com	NS	86400	Target: ns4.p15.dynect.net
xeljanz.com	SOA	1800	MNAME: ns1.p15.dynect.net RNAME: domainregistrations.pfizer.com Serial: 312 Refresh: 3600 Retry: 600 Expire: 604800
xeljanz.com	TXT	1800	TXT: google-site-verification=FXIpBkYQkdvCM2o XASWJRRK3JJuOrbqz1GFyIDPK2bU
xeljanz.com	TXT	1800	TXT: facebook-domain-verification=x5hhz91xf5q ky3thuofobogyfes20e
xeljanz.com	TXT	1800	TXT: v=spf1 a mx include:_spf.pfizer.com -all
xeljanz.com	TXT	1800	TXT: x5hhz91xf5qky3thuofobogyfes20e
xeljanz.com	AAAA	298	IPV6: 2600:9000:2156:ba00:13:12cf:cf00:93a1
xeljanz.com	AAAA	298	IPV6: 2600:9000:2156:4400:13:12cf:cf00:93a1
xeljanz.com	AAAA	298	IPV6: 2600:9000:2156:6200:13:12cf:cf00:93a1
xeljanz.com	AAAA	298	IPV6: 2600:9000:2156:4a00:13:12cf:cf00:93a1
xeljanz.com	AAAA	298	IPV6: 2600:9000:2156:a800:13:12cf:cf00:93a1
xeljanz.com	AAAA	298	IPV6: 2600:9000:2156:c800:13:12cf:cf00:93a1
xeljanz.com	AAAA	298	IPV6: 2600:9000:2156:cc00:13:12cf:cf00:93a1
xeljanz.com	AAAA	298	IPV6: 2600:9000:2156:1800:13:12cf:cf00:93a1

Top Organic Keyword

1.	xeljanz
2.	tofacitinib
3.	enbrel injection
4.	xelsource patient assistance phone number
5.	xeljanz for ulcerative colitis

Top Paid Keyword

1.	xeljanz
2.	ulcerative colitis diet
3.	methotrexate side effects
4.	arthritis treatment
5.	xeljanz prescribing information

Top Referral Site

1.	definition.org
2.	paramountplus.com
3.	askandsearch.com
4.	cbs.com
5.	frontpage.pch.com

Top Destination Site

Not Applicable

Full WHOIS Lookup

Domain Name: XELJANZ.COM
Registry Domain ID:
1546347256_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.markmonitor.com
Registrar URL:
http://www.markmonitor.com
Updated Date:
2021-02-06T10:07:28Z
Creation Date:
2009-03-10T13:08:20Z
Registry Expiry Date:
2023-03-10T13:08:20Z
Registrar: MarkMonitor Inc.
Registrar
IANA ID: 292
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+1.2083895740
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
NS1.P15.DYNECT.NET
Name Server: NS2.P15.DYNECT.NET
Name
Server: NS3.P15.DYNECT.NET
Name Server:
NS4.P15.DYNECT.NET
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2021-06-22T09:38:57Z

Similarly Ranked Websites

Seq — centralized structured logs for .NET, Java, Node.js

- datalust.co

555,409

$ 2,400.00

فروشگاه لوازم یدکی اتومبیل یدکیکو

- yadakico.com

فروشگاه اینترنتی لوازم یدکی انواع اتومبیل یدکیکو, قطعات یدکی خودروهای داخلی و خارجی, لوازم یدکی اورجینال و اصلی انواع خودروهای سواری امکان ارسال قطعات و لوازم یدکی خودرو...

555,411

$ 2,400.00

Sustainable Development Report - Sustainable Development Report

- sdgindex.org

The Sustainable Development Report (including the SDG Index & Dashboards) is a complement to the official SDG indicators and voluntary country-led review processes. The report...

555,414

$ 2,400.00

Телекоммуникационная сеть «Инфолинк»

- infolink.ru

555,418

$ 2,400.00

Γυαλιά Ηλίου - Σκελετοί Οράσως - Φακοί Επαφής - Οπτικά Mati Mati

- matimati.gr

Γυαλιά Ηλίου - Σκελετοί Οράσεως - Φακοί Επαφής. Mati Mati, θα γίνει η αγάπη του καλοκαιριού σας.

555,419

$ 2,400.00

unsafe advertisement

Website stats for Xeljanz - xeljanz.com

Generate Widgets for xeljanz.com

Preview

Code

Preview

Code

Preview

Code

Traffic Report

Estimated Valuation

Search Engine Indexes

Search Engine Backlinks

Safety Information

Website Ranks & Scores

Web Server Information

Traffic Classification

Search Engine Results For xeljanz.com

Enbrel vs. Xeljanz Prescription Treatment for Rheumatoid Arthritis ...

Xeljanz XR Prices, Coupons & Savings Tips - GoodRx

Tofacitinib - Wikipedia

Xeljanz

Xeljanz oral: Uses, Side Effects, Interactions, Pictures, Warnings ...

Xeljanz | European Medicines Agency

Initial safety trial results find increased risk of serious...

XELSOURCE Patient Assistance Program Application

Tofacitinib Citrate (Xeljanz) - American College of Rheumatology

Medications (Text-Based Page) - Infusion Solutions of Delaware

Home Page | XELJANZ® (tofacitinib) | Safety Info

Tips that may help manage life with a chronic illness - AP News

Put Your Health First: Learning What Works for Your Chronic ...

Meet Stephanie: Xeljanz UC patient - Bean LabsBean Labs

Xeljanz/Xeljanz XR | Advertising Profile | See Their Ad Spend ...

Tofacitinib: Drug information - UpToDate

Learn About Xeljanz That: An RX Medicine For Adults with moderate ...

XELJANZ® (tofacitinib citrate) Receives Marketing Authorization in ...

Xeljanz Treats Rheumatoid Arthritis - Overview - YouTube

TOFACITINIB What is Tofacitinib? Tofacitinib (Xeljanz®) is an ...

SPECIALTY QUANTITY LIMIT PROGRAM

Page Resources Breakdown

Homepage Links Analysis

Website Inpage Analysis

Two Phrase Analysis

Four Phrase Analysis

HTTP Header Analysis

Domain Information

Domain Nameserver Information

DNS Record Analysis

Top Organic Keyword

Top Paid Keyword

Top Referral Site

Top Destination Site

Full WHOIS Lookup

Similarly Ranked Websites

Seq — centralized structured logs for .NET, Java, Node.js

فروشگاه لوازم یدکی اتومبیل یدکیکو

Sustainable Development Report - Sustainable Development Report

Телекоммуникационная сеть «Инфолинк»

Γυαλιά Ηλίου - Σκελετοί Οράσως - Φακοί Επαφής - Οπτικά Mati Mati